A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
Objective: This study aimed to analyze the FAERS database to identify adverse event associated with sunitinib to offer valuable insights for the judicious utilization of medication in clinical settings. Methods: Various disproportionality analysis techniques, such as the reporting odds ratio (ROR),...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Elsevier
2024-09-01
|
| سلاسل: | Heliyon |
| الوصول للمادة أونلاين: | http://www.sciencedirect.com/science/article/pii/S2405844024135748 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|